$1.5 Million Award in Autistic Child Tardive Dyskinesia Legal Case
On Feb. 11, 2014, a Chicago jury awarded $1.5 million to an autistic child who developed a severe case of tardive dyskinesia and tardive akathisia while being treated by psychiatrists with Risperdal and then Zyprexa between 2002 and 2007. The drug-induced disorder was diagnosed when he was 15 years old and by then had become disabling and irreversible.
